Press-release for stocks related to financial

Prices are updated after-hours

10-Q: Quarterly report which provides a continuing view of a company's financial position
Published: 2023-05-03 (Crawled : 21:00) - allogene.com
ALLO | $3.48 0.58% 0.57% 2M

| -39.34% | O: -0.35% H: 20.53% C: 13.16%
report financial

Allogene Therapeutics to Report First Quarter 2023 Financial Results on May 3, 2023
Published: 2023-04-25 (Crawled : 13:00) - allogene.com
ALLO | $3.48 0.58% 0.57% 2M

| -35.38% | O: 0.0% H: 9.68% C: 4.28%
report therapeutics financial results

Allogene Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Published: 2023-02-28 (Crawled : 22:00) - allogene.com
ALLO | $3.48 0.58% 0.57% 2M

| -45.35% | O: 6.14% H: 5.93% C: -5.93%
year therapeutics financial update results

Allogene Therapeutics to Report Fourth Quarter and Year-End 2022 Financial Results on February 28, 2023
Published: 2023-02-21 (Crawled : 14:00) - allogene.com
ALLO | $3.48 0.58% 0.57% 2M

| -51.81% | O: -2.08% H: 0.72% C: -5.25%
report therapeutics financial results

Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase
Published: 2022-11-02 (Crawled : 21:00) - allogene.com
ALLO | $3.48 0.58% 0.57% 2M

| -65.88% | O: -7.47% H: 4.2% C: 1.17%
therapeutics financial results

10-Q: Quarterly report which provides a continuing view of a company's financial position
Published: 2022-11-02 (Crawled : 21:00) - allogene.com
ALLO | $3.48 0.58% 0.57% 2M

| -65.88% | O: -7.47% H: 4.2% C: 1.17%
report financial

67%

33%

AGBA | News | $1.26 215.0% 68.25% 130M

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

NVFY | $2.77 31.28% 23.83% 33M

ZCMD | $1.87 28.97% 22.46% 31M

RCON | $0.1112 13.01% 21.28% 1.7M

INSG | $3.03 25.21% 20.13% 330K

GCTK | $0.8191 22.25% 18.2% 190K

WLGS | $0.59 18.0% 17.9% 2.3M

ASNS | $0.828 21.75% 17.86% 18K

Save your searches and get alerts when important news are released.